Table 1.

Baseline Characteristics of the Patients.^a

Groups (N)	Age (years, $\bar{x}\pm s$)	Menstrual Cycle (d, $\bar{x}\pm s$)	Days of Amenorrhea (d, $\bar{x}\pm s$)	β-HCG (IU/L, $\bar{x}\pm s$)	Endometrium Thickness (cm, $\bar{x}\pm s$)	Number of Deliveries (Median With Range)	Number of Pregnancy (Median With Range)
150 mg mf G (484)	27.2 ± 6.8	29.1 ± 1.4	31.1 ± 2.3	756.4 ± 123.2	1.17 ± 0.9	0 (0-1)	1 (1-3)
125 mg mf G (483)	27.1 ± 7.6	29.0 ± 1.5	30.6 ± 2.8	692.3 ± 152.3	1.21 ± 0.5	0 (0-1)	1 (1-3)
100 mg mf G (487)	27.2 ± 8.3	29.2 ± 1.3	31.2 ± 1.8	683.2 ± 168.6	1.20 ± 0.7	0 (0-1)	1 (1-3)
75 mg mf G (486)	27.1 ± 5.2	29.0 ± 1.3	30.6 ± 1.5	629.7 ± 181.1	1.22 ± 0.4	0 (0-1)	1 (1-3)
50 mg mf G (481)	27.3 ± 7.5	29.0 ± 1.1	30.7 ± 1.8	620.4 ± 162.0	1.19 ± 0.3	0 (0-1)	1 (1-3)

Abbreviations: mf, mifepristone; G, group; IU, international unit; β-HCG, β-human chorionic gonadotropin.

^aThere were no significant differences in the above-mentioned baseline characteristics.